Coming soon to Nectar
Allergies come in many forms — from environmental to food to allergic asthma. We’re working on expanding testing and treatment to address every type of allergy.
Delivering comprehensive allergy testing, treatment & care
Nectar Allergy Centers
Kids (under 18)
Asthma and Eczema
Nectar Allergy Centers
Advanced in-person care
Our physical retail locations will allow us to expand the breadth of our care offering. For example, most testing and treatment for food allergies have to be done under the supervision of an allergist, and asthma and eczema need to be diagnosed in person. Our Nectar Allergy Centers will make that possible.
Beyond that, our care centers will seamlessly integrate into our virtual care offering, giving patients the option to get the care they need wherever feels most comfortable for them.
Kids (under 18)
Improve your child's quality of life
We look forward to offering the same testing and treatment to kids as we currently do for adults 18+ with indoor and outdoor allergies. This will offer them a better quality of life long term.
What’s truly exciting about extending this care is that allergy immunotherapy has been shown to prevent the development of asthma in children with allergic rhinoconjunctivitis and potentially prevent new allergies from ever developing.
Food Allergy Testing and Treatment
Discover allergies to certain foods and overcome them
It’s estimated that 33.5 million Americans have food allergies, a number that’s on the rise. In fact, the Centers for Disease Control & Prevention reported that food allergies in children increased by 50% between 1997 and 2011. Financially, caring for children with food allergies costs U.S. families nearly $35 billion in direct costs and $27 billion in indirect costs annually.
We are working to develop targeted allergy testing based on each person’s history instead of the shotgun approach that is often used (i.e. testing for every conceivable allergen). Food desensitization programs, a form of immunotherapy, will be available at our Nectar Allergy Centers, allowing patients to live worry-free from food allergies.
Heal your skin and feel like you, again
Atopic dermatitis, a form of eczema, affects 20 million people in the U.S. Itchiness, redness, dryness, pain, and sleep disturbance are among the top symptoms. It is a financially, socially, and professionally taxing disease. Children with eczema often develop other conditions like food allergies, allergic rhinitis, and asthma. This is referred to as the atopic march. Similarly, over 20% of adults in the U.S. with atopic dermatitis also have asthma and are two to four times as likely to have allergic rhinitis and a food allergy.
Nectar’s eczema treatment will concentrate on improving skin integrity, itchiness, and sleep quality through a combination of lifestyle modifications, topical therapies to help restore the skin barrier, and possibly systemic treatments for severe cases.
Breathe easy and live an active, normal life
Asthma is one of the many ways allergies can manifest themselves in the body. According to the World Health Organization, an estimated 235 million people have asthma worldwide. In the U.S. alone, approximately 41.4 million people have asthma, or every 1 in 13 people.
Nectar’s asthma management will center around diagnostic tools like standardized questionnaires and at-home pulmonary function testing, a noninvasive test that shows how well the lungs are working. This information will help create a customized allergy treatment plan that includes inhalers (short and long-acting beta-agonists), steroids, biologics, and remote patient monitoring.
Leading allergy care innovation
While SLIT drops have been studied extensively and shown to be effective, we are taking this a step further. By conducting clinical research and pivotal studies to observe and learn how SLIT changes our immune response to allergens, we can develop new ways of achieving faster and longer-lasting symptom relief.
Gupta RS, Warren CM, Smith BM, Jiang J, Blumenstock JA, Davis MM, Schleimer RP, Nadeau KC. Prevalence and Severity of Food Allergies Among US Adults. JAMA Network Open 2019; 2(1):e185630.doi:10.1001/jamanetworkopen.2018.5630.
Jackson KD, Howie LD, Akinbami LJ. Trends in allergic conditions among children: United States, 1997-2011. NCHS data brief, no 121. Hyattsville, MD: National Center for Health Statistics. 2013. Retrieved from http://www.cdc.gov/nchs/products/databriefs/db121.htm.
Gupta R, Holdford D, Bilaver L, Dyer A, Holl JL, Meltzer D. The economic impact of childhood food allergy in the United States. JAMA Pediatr. 2013 Nov; 167(11):1026-31.
Centers for Disease Control and Prevention. (2020). 2019 National Health Interview Survey Data. U.S. Department of Health & Human Services. https://www.cdc.gov/asthma/nhis/2019/data.htm (https://www.cdc.gov/asthma/nhis/2019/data.htm)
Silverberg JI, Hanifin JM. Adult eczema prevalence and associations with asthma and other health and demographic factors: a US population-based study. J Allergy Clin Immunol. 2013;132(5):1132-1138.
Spergel JM. Epidemiology of atopic dermatitis and atopic march in children. Immunol Allergy Clin North Am. 2010;30(3):269-280.
Silverberg JI. Comorbidities and the impact of atopic dermatitis. Ann Allergy Asthma Immunol. 2019;123(2):144-151.